DrugCite
Search

RIFAMPIN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Rifampin Adverse Events Reported to the FDA Over Time

How are Rifampin adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Rifampin, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Rifampin is flagged as the suspect drug causing the adverse event.

Most Common Rifampin Adverse Events Reported to the FDA

What are the most common Rifampin adverse events reported to the FDA?

Pyrexia
56 (1.98%)
Aspartate Aminotransferase Increase...
49 (1.73%)
Alanine Aminotransferase Increased
48 (1.69%)
Drug Interaction
43 (1.52%)
Renal Failure Acute
38 (1.34%)
Hepatitis
37 (1.31%)
Nausea
37 (1.31%)
Vomiting
35 (1.23%)
Thrombocytopenia
34 (1.2%)
Neutropenia
27 (.95%)
Blood Bilirubin Increased
24 (.85%)
Show More Show More
Diarrhoea
24 (.85%)
Condition Aggravated
22 (.78%)
Pruritus
22 (.78%)
Drug Eruption
21 (.74%)
Hepatic Failure
21 (.74%)
Rash
21 (.74%)
Anaemia
20 (.71%)
Hepatotoxicity
19 (.67%)
Jaundice
19 (.67%)
Leukopenia
19 (.67%)
Erythema
18 (.63%)
Drug Ineffective
17 (.6%)
Fatigue
17 (.6%)
Headache
17 (.6%)
Hypotension
17 (.6%)
Asthenia
16 (.56%)
Chills
16 (.56%)
Cytolytic Hepatitis
16 (.56%)
Paradoxical Drug Reaction
16 (.56%)
Confusional State
15 (.53%)
General Physical Health Deteriorati...
15 (.53%)
Abdominal Pain
14 (.49%)
Death
14 (.49%)
Dyspnoea
14 (.49%)
Rash Erythematous
14 (.49%)
Blood Alkaline Phosphatase Increase...
13 (.46%)
Blood Creatinine Increased
13 (.46%)
Cholestasis
13 (.46%)
Decreased Appetite
13 (.46%)
Dizziness
13 (.46%)
Drug Hypersensitivity
13 (.46%)
Haemoglobin Decreased
13 (.46%)
Hepatic Necrosis
13 (.46%)
Hepatitis Fulminant
13 (.46%)
Acute Hepatic Failure
12 (.42%)
Deep Vein Thrombosis
12 (.42%)
Drug Rash With Eosinophilia And Sys...
12 (.42%)
Hypersensitivity
12 (.42%)
Renal Failure
12 (.42%)
Dehydration
11 (.39%)
Hepatic Encephalopathy
11 (.39%)
Immune Reconstitution Syndrome
11 (.39%)
Metabolic Acidosis
11 (.39%)
Renal Impairment
11 (.39%)
Scab
11 (.39%)
Sepsis
11 (.39%)
Tuberculosis
11 (.39%)
Anorexia
10 (.35%)
Arthralgia
10 (.35%)
Disseminated Tuberculosis
10 (.35%)
Eczema
10 (.35%)
Malaise
10 (.35%)
Myalgia
10 (.35%)
Myocardial Infarction
10 (.35%)
Staphylococcal Infection
10 (.35%)
Tubulointerstitial Nephritis
10 (.35%)
Weight Decreased
10 (.35%)
Wound
10 (.35%)
Wound Secretion
10 (.35%)
Cough
9 (.32%)
Disseminated Intravascular Coagulat...
9 (.32%)
Liver Transplant
9 (.32%)
Oedema Peripheral
9 (.32%)
Pleural Effusion
9 (.32%)
Transaminases Increased
9 (.32%)
Chromaturia
8 (.28%)
Drug Toxicity
8 (.28%)
Haemodialysis
8 (.28%)
Hyponatraemia
8 (.28%)
Liver Disorder
8 (.28%)
Lymphadenopathy
8 (.28%)
Pulmonary Tuberculosis
8 (.28%)
Skin Exfoliation
8 (.28%)
Toxic Epidermal Necrolysis
8 (.28%)
Anxiety
7 (.25%)
Blood Lactate Dehydrogenase Increas...
7 (.25%)
Coagulopathy
7 (.25%)
Convulsion
7 (.25%)
Dermatitis Exfoliative
7 (.25%)
Dyspepsia
7 (.25%)
Eosinophilia
7 (.25%)
Gamma-glutamyltransferase Increased
7 (.25%)
Hypertension
7 (.25%)
Liver Function Test Abnormal
7 (.25%)
Lung Infiltration
7 (.25%)
Neuroleptic Malignant Syndrome
7 (.25%)
Oral Candidiasis
7 (.25%)
Pneumonia
7 (.25%)
Rash Macular
7 (.25%)
Septic Shock
7 (.25%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Rifampin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Rifampin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Rifampin

What are the most common Rifampin adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Rifampin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Rifampin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Rifampin According to Those Reporting Adverse Events

Why are people taking Rifampin, according to those reporting adverse events to the FDA?

Tuberculosis
290
Pulmonary Tuberculosis
66
Product Used For Unknown Indication
59
Drug Use For Unknown Indication
30
Staphylococcal Infection
26
Antibiotic Prophylaxis
22
Show More Show More
Disseminated Tuberculosis
18
Mycobacterium Avium Complex Infecti...
17
Osteomyelitis
17
Infection
14
Prophylaxis
12
Tuberculin Test Positive
11
Latent Tuberculosis
10
Pneumonia
9
Atypical Mycobacterial Infection
8
Cellulitis
8
Brucellosis
7
Endocarditis
7
Lymph Node Tuberculosis
7
Bacterial Infection
6
Tuberculosis Prophylaxis
6
Postoperative Wound Infection
5
Pruritus
4
Bacteraemia
4
Crohns Disease
4
Lung Infection
4
Lymphadenitis
4
Pyrexia
4
Abscess
3
Ill-defined Disorder
3
Mycobacterial Infection
3
Mycobacterium Ulcerans Infection
3
Mycobacterium Tuberculosis Complex ...
3
Exposure To Communicable Disease
3
Tuberculous Pleurisy
3
Meningitis
3
Tuberculosis Skin Test Positive
3
Endocarditis Staphylococcal
3
Listeriosis
2
Aspergillosis
2
Bone Tuberculosis
2
Tuberculosis Gastrointestinal
2
Maternal Exposure During Pregnancy
2
Antibiotic Therapy
2
Infection Prophylaxis
2
Extrapulmonary Tuberculosis
2
Antibiotic Resistant Staphylococcus...
2
Leprosy
2
Meningitis Tuberculous
2
Pleurisy
2
Extradural Abscess
2

Drug Labels

LabelLabelerEffective
RifampinBryant Ranch Prepack02-JAN-98
RifampinState of Florida DOH Central Pharmacy01-JUN-10
RifampinRebel Distributors Corp27-DEC-10
RifampinPhysicians Total Care, Inc.17-JAN-11
RifampinVersaPharm Incorporated08-MAR-11
RifampinREMEDYREPACK INC. 28-MAR-11
RifampinREMEDYREPACK INC. 20-JUN-11
RifampinREMEDYREPACK INC. 03-AUG-11
RifampinVersaPharm Incorporated04-AUG-11
RifampinPfizer Laboratories Div Pfizer Inc06-SEP-11
Rifatersanofi-aventis U.S. LLC07-OCT-11
RifampinRebel Distributors Corp13-DEC-11
RifampinH.J. Harkins Company, Inc.19-JAN-12
RifampinAmerican Health Packaging28-FEB-12
Rifamatesanofi-aventis U.S. LLC07-MAR-12
IsonarifVersaPharm Incorporated27-MAR-12
RifampinAKORN INC.02-MAY-12
RifampinMajor Pharmaceuticals30-AUG-12
RifampinMylan Institutional Inc.09-NOV-12
RifampinEon Labs, Inc.07-MAR-13
RifampinBedford Laboratories15-MAR-13
RifampinCardinal Health20-MAR-13
RifampinCardinal Health20-MAR-13
RifampinLannett Company, Inc.21-MAR-13
Rifadin IvSanofi-Aventis U.S. LLC09-APR-13
RifadinSanofi-Aventis U.S. LLC09-APR-13
Rifatersanofi-aventis U.S. LLC19-APR-13

Rifampin Case Reports

What Rifampin safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Rifampin. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Rifampin.